RSV is the leading reason babies under 12 months old end up in the hospital, and an estimated 100-300 kids under age 5 die from it in the U.S. every year.
States reconsider religious exemptions for vaccinations in child care
Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon.
Pfizer and BioNTech’s combo flu/COVID vax shows strong immune response
Pfizer slashed the guidance for revenues of Paxlovid by $7 billion, which includes a $4.2 billion non-cash revenue reversal for the return of the nearly 8 million treatment courses from the U.S. government inventory.
The new vaccines and you: Americans better armed than ever against the winter blechs
A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.
Moderna’s combo flu and COVID-19 vaccine shows efficacy in Phase 1/2 trial